For the quarter ending 2026-03-31, CVSI made $3,195K in revenue. -$643K in net income. Net profit margin of -20.13%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-03-31 |
|---|---|---|---|---|
| Product sales, net | 3,195 | 3,497* | 3,256 | 3,606 |
| Cost of goods sold | 1,633 | 1,600* | 1,677 | 1,948 |
| Gross profit | 1,562 | 1,897* | 1,579 | 1,658 |
| Research and development | 18 | 41* | 24 | 30 |
| Selling, general and administrative | 1,862 | 1,669* | 1,830 | 2,139 |
| Benefit from reversal of accrued payroll taxes (note 11) | 0 | 261* | 0 | -522 |
| Total operating expenses | 1,880 | 1,971* | 1,854 | 1,647 |
| Operating income (loss) | -318 | -74* | -275 | 11 |
| Other expense, net | - | - | - | -151 |
| Loss on extinguishment of debt | 20 | -19* | 0 | 38 |
| Change in fair value of convertible notes payable | 252 | - | - | - |
| Interest expense, net | 93 | 129* | 107 | - |
| Loss before income taxes | -643 | -222* | -382 | -102 |
| Income tax expense | 0 | -1* | 0 | 7 |
| Net loss | -643 | -221 | -382 | -109 |
| Basic EPS | 0 | -0.001 | 0 | 0 |
| Diluted EPS | 0 | -0.001 | 0 | 0 |
| Basic Average Shares | 186,920,000 | 184,264,000 | 184,264,000 | 184,264,000 |
| Diluted Average Shares | 186,920,000 | 184,264,000 | 184,264,000 | 184,264,000 |
CV Sciences, Inc. (CVSI)
CV Sciences, Inc. (CVSI)